GNRH1 and urinary tract obstruction: No significant difference in the absolute comorbidity rate of obstructive uropathy between GnRH agonists (9.4%), hybrids (9.4%), and antagonist (14.8%) was observed, although a (not statistically significant) trend was found in favor of agonists and hybrids.